Basic principles in thrombolysis: regulatory role of plasminogen

Area of Science:

• Biochemistry
• Hematology
• Pharmacology

Background:

• Thrombolytic therapy utilizes plasminogen activators to stimulate the fibrinolytic system.
• The fibrinolytic system converts plasminogen to plasmin, a key enzyme in clot breakdown.
• Understanding the regulation of fibrinolysis is crucial for effective thrombolytic treatments.

Purpose of the Study:

• To elucidate the regulatory role of plasminogen in the fibrinolytic process during thrombolytic therapy.
• To explain the mechanisms underlying the two-phase fibrinolysis.
• To highlight the impact of thrombin-activatable fibrinolysis inhibitor (TAFI) on fibrinolysis.

Main Methods:

• The study describes the biochemical mechanisms of fibrinolysis.
• It details the interaction between plasminogen, fibrin, and plasminogen activators.
• The role of carboxyterminal lysine residues and TAFI in regulating fibrinolysis is discussed.

Main Results:

• Fibrinolysis occurs in two phases, initiated by plasminogen binding to intact fibrin.
• Generated carboxyterminal lysine residues create new binding sites, accelerating fibrinolysis in the second phase.
• Plasminogen activators like scu-PA and staphylokinase exhibit fibrin-selectivity due to preferential binding.
• TAFI inhibits the second phase of fibrinolysis by removing these lysine residues.

Conclusions:

• Plasminogen plays a critical regulatory role in both fibrinolysis and thrombolysis.
• The two-phase fibrinolytic process is modulated by plasminogen availability and reactivity.
• TAFI acts as an inhibitor by disrupting the positive feedback loop of fibrinolysis.